Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval
Guided Therapeutics, Inc. or the "Company" (OTCQB:GTHP), the maker of LuViva, a rapid and painless cervical cancer detection system based on the Company's patented biophotonic technology, announced today it had executed
BusinesswireDec 21, 2022 09:05 ET
Guided Therapeutics Receives Institutional Review Board Approval to Start Clinical Study for FDA Approval of the LuViva® Advanced Cervical Scan
Guided Therapeutics, Inc. (OTCQB:GTHP), the maker of a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology, announced that it has obtained Institutional Review Board (IRB) approval to initiate i
BusinessWireJul 20, 2022 09:05 ET
No Data
No Data